Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers
Not Applicable
Completed
- Conditions
- Photoaging
- Interventions
- Device: In a double-blinded fashion, 250 mg CANNAXR creamDevice: Topical VEHICLE cream
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- MINO Labs, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT05279495
- Locations
- 🇺🇸
Center for Clinical and Cosmetic Research, Aventura, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath